Taiho Ventures
Investor profile
Venture capital
Also recorded as: Taiho Ventures LLC
Deals
7
distinct rounds
Companies
5
backed
Active span
2021–2026
6 yrs
Total round €
€146M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- M Ventures3
- IP Group PLC2
- Kizoo Technology Ventures2
- Pfizer Ventures2
- UTokyo Innovation Platform2
- Beiersdorf1
- Bioqube Ventures1
- Bristol Myers Squibb1
- Cambridge Innovation Capital1
- Epidarex Capital1
- Fast Track Initiative1
- Fast Track Initiative (FTI)1
- INKEF Capital1
- Lifeforce Capital1
- Magnetic Ventures1
- MRL Ventures Fund1
- Northpond Ventures1
- Seroba Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Storm Therapeutics | UK | 2 | €76M |
| Transition Bio | UK | 1 | €47M |
| cellvie | Switzerland | 2 | €9.4M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Theolytics | UK | 1 | €5.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Storm Therapeutics | Series C | €48M | 2026-04 |
| Transition Bio | Series A | €47M | 2022-06 |
| Storm Therapeutics | Series B | €28M | 2022-12 |
| Anavo Therapeutics | Seed | €8.5M | 2023-05 |
| Theolytics | Series A | €5.5M | 2021-01 |
| cellvie | Other | €5.1M | 2023-02 |
| cellvie | Other | €4.3M | 2025-09 |